prednisolone has been researched along with Central Serous Chorioretinopathy in 7 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 36-year-old woman was diagnosed with systemic lupus erythematosus (SLE)." | 1.39 | Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. ( Ito, S; Kuroda, T; Murakami, S; Murasawa, A; Nagai, S; Nakano, M; Narita, I; Sato, H; Wada, Y, 2013) |
| "We report a case of a patient with ulcerative colitis and central serous retinopathy, which is a chronic ophthalmological condition that is frequently aggravated by corticosteroid treatment and may sometimes result in severe visual impairment." | 1.39 | A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma. ( Ben-Horin, S; Geyshis, B; Katz, G; Kopylov, U, 2013) |
| " Correlation between daily corticosteroid dosage and remission time and factors relating to final visual acuity of <20/40 were studied." | 1.37 | Central serous chorioretinopathy after renal transplantation. ( Byeon, SH; Kang, EC; Koh, HJ; Lee, CS; Lee, KS; Lee, SC, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Takashi, N | 1 |
| Nakamura, A | 1 |
| Kataoka, K | 1 |
| Usui, Y | 1 |
| Ito, Y | 1 |
| Kaneko, H | 1 |
| Han, JM | 1 |
| Hwang, JM | 1 |
| Kim, JS | 1 |
| Park, KH | 1 |
| Woo, SJ | 1 |
| Gao, X | 1 |
| Li, X | 1 |
| Lee, CS | 1 |
| Kang, EC | 1 |
| Lee, KS | 1 |
| Byeon, SH | 1 |
| Koh, HJ | 1 |
| Lee, SC | 1 |
| Sato, H | 1 |
| Ito, S | 1 |
| Nagai, S | 1 |
| Murasawa, A | 1 |
| Wada, Y | 1 |
| Murakami, S | 1 |
| Kuroda, T | 1 |
| Nakano, M | 1 |
| Narita, I | 1 |
| Geyshis, B | 1 |
| Katz, G | 1 |
| Ben-Horin, S | 1 |
| Kopylov, U | 1 |
| Katsanos, A | 1 |
| Stefaniotou, M | 1 |
7 other studies available for prednisolone and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Optical coherence tomography angiography for the diagnosis of granulomatosis with polyangiitis with serous retinal detachment: A case report.
Topics: Administration, Oral; Adult; Central Serous Chorioretinopathy; Disease Progression; Fluorescein Angi | 2021 |
Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study.
Topics: Administration, Oral; Adult; Aged; Central Serous Chorioretinopathy; Choroid; Dose-Response Relation | 2014 |
Development of bullous retinal detachment during systemic corticosteroid treatment.
Topics: Administration, Oral; Central Serous Chorioretinopathy; Diagnostic Errors; Female; Fluorescein Angio | 2011 |
Central serous chorioretinopathy after renal transplantation.
Topics: Adult; Central Serous Chorioretinopathy; Drug Therapy, Combination; Female; Glucocorticoids; Graft R | 2011 |
Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid.
Topics: Adult; Central Serous Chorioretinopathy; Dose-Response Relationship, Drug; Drug Therapy, Combination | 2013 |
A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Central Serous Chorioretinopathy; | 2013 |
Central serous chorioretinopathy in patients who cannot discontinue steroids.
Topics: Anti-Inflammatory Agents; Central Serous Chorioretinopathy; Colitis, Ulcerative; Humans; Hydrocortis | 2013 |